Research
Open Access
Determinants of guideline-concordant breast cancer screening by family physicians for women aged 40–49 years: a qualitative analysis
Michelle B. Nadler, Ann Marie Corrado, Laura Desveaux, Sarah E. Neil-Sztramko, Brooke E. Wilson, Alexandra Desnoyers, Eitan Amir and Noah Ivers
October 18, 2022 10 (4) E900-E910; DOI: https://doi.org/10.9778/cmajo.20210266
Michelle B. Nadler
Division of Medical Oncology & Hematology, Department of Medicine (Nadler, Wilson, Desnoyers, Amir), Princess Margaret Cancer Centre; Department of Medicine (Nadler, Wilson, Desnoyers, Amir), University of Toronto; The Peter Gilgan Centre for Women’s Cancers (Corrado, Ivers), Women’s College Hospital; Institute for Better Health (Desveaux), Trillium Health Partners; Institute of Health Policy, Management and Evaluation (Desveaux, Amir, Ivers), Dalla Lana School of Public Health, University of Toronto; Women’s College Hospital Institute for Health System Solutions and Virtual Care (Desveaux), Toronto, Ont.; Department of Health Research Methods, Evidence & Impact, Faculty of Health Sciences (Neil-Sztramko), McMaster University, Hamilton Ont.; University of New South Wales (Wilson, Ivers), Sydney, Australia; Department of Family and Community Medicine (Ivers), University of Toronto, Toronto, Ont.
MD MScAnn Marie Corrado
Division of Medical Oncology & Hematology, Department of Medicine (Nadler, Wilson, Desnoyers, Amir), Princess Margaret Cancer Centre; Department of Medicine (Nadler, Wilson, Desnoyers, Amir), University of Toronto; The Peter Gilgan Centre for Women’s Cancers (Corrado, Ivers), Women’s College Hospital; Institute for Better Health (Desveaux), Trillium Health Partners; Institute of Health Policy, Management and Evaluation (Desveaux, Amir, Ivers), Dalla Lana School of Public Health, University of Toronto; Women’s College Hospital Institute for Health System Solutions and Virtual Care (Desveaux), Toronto, Ont.; Department of Health Research Methods, Evidence & Impact, Faculty of Health Sciences (Neil-Sztramko), McMaster University, Hamilton Ont.; University of New South Wales (Wilson, Ivers), Sydney, Australia; Department of Family and Community Medicine (Ivers), University of Toronto, Toronto, Ont.
MScLaura Desveaux
Division of Medical Oncology & Hematology, Department of Medicine (Nadler, Wilson, Desnoyers, Amir), Princess Margaret Cancer Centre; Department of Medicine (Nadler, Wilson, Desnoyers, Amir), University of Toronto; The Peter Gilgan Centre for Women’s Cancers (Corrado, Ivers), Women’s College Hospital; Institute for Better Health (Desveaux), Trillium Health Partners; Institute of Health Policy, Management and Evaluation (Desveaux, Amir, Ivers), Dalla Lana School of Public Health, University of Toronto; Women’s College Hospital Institute for Health System Solutions and Virtual Care (Desveaux), Toronto, Ont.; Department of Health Research Methods, Evidence & Impact, Faculty of Health Sciences (Neil-Sztramko), McMaster University, Hamilton Ont.; University of New South Wales (Wilson, Ivers), Sydney, Australia; Department of Family and Community Medicine (Ivers), University of Toronto, Toronto, Ont.
MScPT PhDSarah E. Neil-Sztramko
Division of Medical Oncology & Hematology, Department of Medicine (Nadler, Wilson, Desnoyers, Amir), Princess Margaret Cancer Centre; Department of Medicine (Nadler, Wilson, Desnoyers, Amir), University of Toronto; The Peter Gilgan Centre for Women’s Cancers (Corrado, Ivers), Women’s College Hospital; Institute for Better Health (Desveaux), Trillium Health Partners; Institute of Health Policy, Management and Evaluation (Desveaux, Amir, Ivers), Dalla Lana School of Public Health, University of Toronto; Women’s College Hospital Institute for Health System Solutions and Virtual Care (Desveaux), Toronto, Ont.; Department of Health Research Methods, Evidence & Impact, Faculty of Health Sciences (Neil-Sztramko), McMaster University, Hamilton Ont.; University of New South Wales (Wilson, Ivers), Sydney, Australia; Department of Family and Community Medicine (Ivers), University of Toronto, Toronto, Ont.
PhDBrooke E. Wilson
Division of Medical Oncology & Hematology, Department of Medicine (Nadler, Wilson, Desnoyers, Amir), Princess Margaret Cancer Centre; Department of Medicine (Nadler, Wilson, Desnoyers, Amir), University of Toronto; The Peter Gilgan Centre for Women’s Cancers (Corrado, Ivers), Women’s College Hospital; Institute for Better Health (Desveaux), Trillium Health Partners; Institute of Health Policy, Management and Evaluation (Desveaux, Amir, Ivers), Dalla Lana School of Public Health, University of Toronto; Women’s College Hospital Institute for Health System Solutions and Virtual Care (Desveaux), Toronto, Ont.; Department of Health Research Methods, Evidence & Impact, Faculty of Health Sciences (Neil-Sztramko), McMaster University, Hamilton Ont.; University of New South Wales (Wilson, Ivers), Sydney, Australia; Department of Family and Community Medicine (Ivers), University of Toronto, Toronto, Ont.
MDAlexandra Desnoyers
Division of Medical Oncology & Hematology, Department of Medicine (Nadler, Wilson, Desnoyers, Amir), Princess Margaret Cancer Centre; Department of Medicine (Nadler, Wilson, Desnoyers, Amir), University of Toronto; The Peter Gilgan Centre for Women’s Cancers (Corrado, Ivers), Women’s College Hospital; Institute for Better Health (Desveaux), Trillium Health Partners; Institute of Health Policy, Management and Evaluation (Desveaux, Amir, Ivers), Dalla Lana School of Public Health, University of Toronto; Women’s College Hospital Institute for Health System Solutions and Virtual Care (Desveaux), Toronto, Ont.; Department of Health Research Methods, Evidence & Impact, Faculty of Health Sciences (Neil-Sztramko), McMaster University, Hamilton Ont.; University of New South Wales (Wilson, Ivers), Sydney, Australia; Department of Family and Community Medicine (Ivers), University of Toronto, Toronto, Ont.
MDEitan Amir
Division of Medical Oncology & Hematology, Department of Medicine (Nadler, Wilson, Desnoyers, Amir), Princess Margaret Cancer Centre; Department of Medicine (Nadler, Wilson, Desnoyers, Amir), University of Toronto; The Peter Gilgan Centre for Women’s Cancers (Corrado, Ivers), Women’s College Hospital; Institute for Better Health (Desveaux), Trillium Health Partners; Institute of Health Policy, Management and Evaluation (Desveaux, Amir, Ivers), Dalla Lana School of Public Health, University of Toronto; Women’s College Hospital Institute for Health System Solutions and Virtual Care (Desveaux), Toronto, Ont.; Department of Health Research Methods, Evidence & Impact, Faculty of Health Sciences (Neil-Sztramko), McMaster University, Hamilton Ont.; University of New South Wales (Wilson, Ivers), Sydney, Australia; Department of Family and Community Medicine (Ivers), University of Toronto, Toronto, Ont.
MD PhDNoah Ivers
Division of Medical Oncology & Hematology, Department of Medicine (Nadler, Wilson, Desnoyers, Amir), Princess Margaret Cancer Centre; Department of Medicine (Nadler, Wilson, Desnoyers, Amir), University of Toronto; The Peter Gilgan Centre for Women’s Cancers (Corrado, Ivers), Women’s College Hospital; Institute for Better Health (Desveaux), Trillium Health Partners; Institute of Health Policy, Management and Evaluation (Desveaux, Amir, Ivers), Dalla Lana School of Public Health, University of Toronto; Women’s College Hospital Institute for Health System Solutions and Virtual Care (Desveaux), Toronto, Ont.; Department of Health Research Methods, Evidence & Impact, Faculty of Health Sciences (Neil-Sztramko), McMaster University, Hamilton Ont.; University of New South Wales (Wilson, Ivers), Sydney, Australia; Department of Family and Community Medicine (Ivers), University of Toronto, Toronto, Ont.
MD PhDData supplements
Online appendices
Related Articles
In this issue
Article tools
Respond to this article
Determinants of guideline-concordant breast cancer screening by family physicians for women aged 40–49 years: a qualitative analysis
Michelle B. Nadler, Ann Marie Corrado, Laura Desveaux, Sarah E. Neil-Sztramko, Brooke E. Wilson, Alexandra Desnoyers, Eitan Amir, Noah Ivers
Sep 2022, 10 (4) E900-E910; DOI: 10.9778/cmajo.20210266
Determinants of guideline-concordant breast cancer screening by family physicians for women aged 40–49 years: a qualitative analysis
Michelle B. Nadler, Ann Marie Corrado, Laura Desveaux, Sarah E. Neil-Sztramko, Brooke E. Wilson, Alexandra Desnoyers, Eitan Amir, Noah Ivers
Sep 2022, 10 (4) E900-E910; DOI: 10.9778/cmajo.20210266
Related Articles
Cited By...
- No citing articles found.